Aim Bulletin
Tertiary Minerals completes first drill hole at Pyramid project
Tertiary Minerals updated the market on its first drill hole at the Pyramid Gold Project in Nevada on Monday, reporting that the drill rig had been mobilised ahead of schedule, and the hole been successfully completed and drilled to a total depth of 137 metres.
Caledonian Trust amends deal to sell St Margaret's House
Property investment and development company Caledonian Trust updated the market on its proposed sale of St Margaret's House on London Road in Edinburgh to Drum Property Group on Monday.
Futura files for second FDA meeting over erection gel
Futura Medical has filed for a further pre-submission meeting with the US Food and Drug Administration (FDA), it announced on Monday, following receipt of the complete and signed clinical study report for its phase 3 Study, ‘FM57’.
RBC ups rating on Abcam, despite revenue warning
RBC Capital Markets has upgraded its rating on Abcam to ‘outperform’, despite the life sciences specialist warning on revenues.
Ixico in 'robust' position to handle short-term Covid-19 headwinds
Data analytics firm Ixico said on Monday that it was in a "robust" position to handle short-term headwinds stemming from the Covid-19 pandemic and associated government measures.
4D Pharma receives expedited approval for coronavirus study
Pharmaceutical company 4D Pharma received expedited acceptance from the UK Medicines and Healthcare Products Regulatory Agency on Monday to kick off a Phase II study of MRx-4DP0004 in patients with Covid-19.
Shanta Gold pleased with first quarter performance
East Africa-focussed gold producer Shanta Gold updated the market on production and operations for the first quarter at the New Luika Gold Mine in south western Tanzania on Monday, reporting gold production of 20,167 ounces, up from 19,550 ounces in the fourth quarter.
Litigation Capital Management concludes joint venture with Vannin
Disputes financing company Litigation Capital Management announced the conclusion of its joint venture arrangement with Vannin Capital, and associated profit of AUD 2. 45m (£1. 25m) on Monday.
Secure Income begins action to recover rent from Travelodge
Secure Income REIT responded to recent press coverage around the Travelodge chain of budget hotels on Monday, confirming that the outstanding quarter's rent due from Travelodge amounted to 6. 4% of its annual rental income.
Proactis maintains full-year guidance
Spend management solutions provider Proactis maintained its full-year guidance on Monday, saying it had responded well to a "period of significant disruption and uncertainty".
Totally earnings to beat consensus despite weaker revenues
Healthcare services provider Totally expects underlying earnings to come in ahead of consensus for the year ended 31 March despite revenues falling short of expectations.
Abcam warns on revenues as Covid-19 hits markets
Life sciences tools provider Abcam warned on full-year revenues on Monday as the Covid-19 pandemic began to take its toll across the group's markets.
Angus Energy secures £1.4m through convertible loan note
Angus Energy has issued a 4% per annum £1. 4m convertible loan note to significant shareholder Knowe Properties, it announced on Monday.
Omega Diagnostics inks deal with Mologic over Covid-19 antibody test
Medical diagnostics company Omega Diagnostics has signed a material transfer agreement with Mologic, it announced on Monday, to formalise a partnership to provide manufacturing capability for Mologic's Covid-19 first generation ‘ELISA’ diagnostics test.
Trinity Exploration confident amid low oil price environment
Trinidad and Tobago-focussed Trinity Exploration & Production updated the market on its first quarter of operations on Monday, reporting that it had responded “rapidly and comprehensively” to the impact of the Covid-19 coronavirus pandemic and the OPEC+ standoff.
Cerillion trading 'resilient' amid coronavirus pandemic
Billing and customer relationship management software provider Cerillion updated the market on trading in its first half on Monday, saying it had traded “strongly” in the six months ended 31 March, in line with management expectations.
Tissue Regenix gets another $0.42m under US Covid support scheme
Regenerative medical devices company Tissue Regenix Group has received a further $0. 42m loan under the United States government-backed Covid-19 business support scheme, it announced on Monday.